Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease: Can We Predict its Development?

Pietro Scicchitano, Francesca Cortese, Michele Gesualdo, Tommaso Acquaviva, Emanuela De Cillis, Alessandro Santo Bortone, Marco Matteo Ciccone

References


Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57. doi: 10.1093/eurheartj/ehq249.

Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A, Dimopoulos K, Swan L, Gatzoulis MA, Diller GP. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014 Mar;35(11):725-32. doi: 10.1093/eurheartj/eht257.

Agarwal S, Sud K, Menon V. Nationwide Hospitalization Trends in Adult Congenital Heart Disease Across 2003-2012. J Am Heart Assoc. 2016 Jan 19;5(1). pii: e002330. doi:10.1161/JAHA.115.002330.

Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007 Feb 27;115(8):1039-50. doi: 10.1161/CIRCULATIONAHA.105.592386

van Riel AC, Schuuring MJ, van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CL, Hoorntje JC, Wagenaar LJ, Post MC, van Dijk AP, Hoendermis ES, Mulder BJ, Bouma BJ. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014 Jun 15;174(2):299-305. doi: 10.1016/j.ijcard.2014.04.072.

Ghosh S, Chatterjee S, Black E, Firmin RK. Surgical closure of atrial septal defects in adults: effect of age at operation on outcome. Heart. 2002 Nov;88(5):485-7. doi:10.1136/heart.88.5.485

de Lezo JS, Medina A, Romero M, Pan M, Segura J, Caballero E, Pavlovic D, Ortega JR, Franco M, Delgado A, Ojeda S, Mesa D, Lafuente M. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J. 2002 Nov;144(5):877-80. doi:10.1067/mhj.2002.126121

Ströker E, Van De Bruaene A, De Meester P, Van Deyck K, Gewillig M, Budts W. Transcatheter device closure of atrial septal defects in patients above age 60. Acta Cardiol. 2013 Apr;68(2):127-32. doi: 10.2143/AC.68.2.2967268

Khan AA, Tan JL, Li W, Dimopoulos K, Spence MS, Chow P, Mullen MJ. The impact of transcatheter atrial septal defect closure in the older population: a prospective study. JACC Cardiovasc Interv. 2010 Mar;3(3):276-81. doi: 10.1016/j.jcin.2009.12.011.

Humenberger M, Rosenhek R, Gabriel H, Rader F, Heger M, Klaar U, Binder T, Probst P, Heinze G, Maurer G, Baumgartner H. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2011 Mar;32(5):553-60. doi: 10.1093/eurheartj/ehq352.

Ebenroth ES, Hurwitz RA, Cordes TM. Late onset of pulmonary hypertension after successful Mustard surgery for d-transposition of the great arteries. Am J Cardiol. 2000 Jan 1;85(1):127-30, A10. DOI: 10.1016/S0002-9149(99)00625-6

Chan E, Alejos J. Pulmonary hypertension in patients after repair of transposition of the great arteries. Congenit Heart Dis. 2010 Mar-Apr;5(2):161-4. doi: 10.1111/j.1747-0803.2009.00321.x.

van Riel AC, Blok IM, Zwinderman AH, Wajon EM, Sadee AS, Bakker-de Boo M, van Dijk AP, Hoendermis ES, Riezebos RK, Mulder BJ, Bouma BJ. Lifetime Risk of Pulmonary Hypertension for All Patients After Shunt Closure. J Am Coll Cardiol. 2015 Sep 1;66(9):1084-6. doi: 10.1016/j.jacc.2015.06.1318.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barberà J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol Ç, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Völler H, Luis Zamorano J. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317.

Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, Horlick E, Granton J, Silversides CK. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart. 2008 Sep;94(9):1189-93. doi:10.1136/hrt.2006.114660

Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol. 2011 Jul 26;58(5):538-46. doi: 10.1016/j.jacc.2011.03.033.

Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, Ruíz JM, González IO, Cubero JS, del Cerro MJ, Salvador ML, Dos Subira L, Gallego P, Escribano-Subias P; REHAP investigators. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry. Int J Cardiol. 2015 Apr 1;184:717-23. doi: 10.1016/j.ijcard.2015.02.031.

Scognamiglio G, Kempny A, Price LC, Alonso-Gonzalez R, Marino P, Swan L, D' Alto M, Hooper J, Gatzoulis MA, Dimopoulos K, Wort SJ. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value. Heart. 2014 Sep;100(17):1335-41. doi: 10.1136/heartjnl-2014-305494.

Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Straalen JP, Boekholdt SM, Tijssen JG, Mulder BJ, Bouma BJ. High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. Congenit Heart Dis. 2013 Nov-Dec;8(6):520-6. doi: 10.1111/chd.12022.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v8i0.259

Copyright (c) 2016 Pietro Scicchitano, Francesca Cortese, Michele Gesualdo, Tommaso Acquaviva, Emanuela De Cillis, Alessandro Santo Bortone, Marco Matteo Ciccone

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.